Bacterial Sepsis among Children with Congenital Heart Disease in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.


Journal

Ethiopian journal of health sciences
ISSN: 2413-7170
Titre abrégé: Ethiop J Health Sci
Pays: Ethiopia
ID NLM: 101224773

Informations de publication

Date de publication:
May 2022
Historique:
received: 05 12 2021
accepted: 20 01 2022
entrez: 11 7 2022
pubmed: 12 7 2022
medline: 14 7 2022
Statut: ppublish

Résumé

Bacterial Sepsis is a serious medical problem affecting children with Congenital Heart Disease (CHD). The pattern and factors predicting outcome of bacterial sepsis have not been studied in Africa. The study aimed to describe the pattern and outcome of bacterial sepsis among children with CHD in Tikur Anbessa Specialized Hospital (TASH). A cross-sectional study was carried out among children with CHD and sepsis at TASH between May 2017 and July 2020. Structured questionnaires were used for data collection. Statistical significance was set at P value < 0.05, and multivariable logistic regression was used to determine predictors. This study included 384 CHD children with sepsis. Proportion of culture proven bacterial sepsis was 17.1 % (66) (95% CI: 13.6-21.3). Coagulase negative staphylococcus aureus 7% (27), Staphylococcus aureus 4.4% (17) and Actinobacteria 1.8% (7) were the common isolated bacteriological agents. Death was documented in 25% (96) of study subjects. Down syndrome subjects were 2.4 times [aOR=2.416 (95%CI: 1.367-4.264)] more likely to die from sepsis. Those with associated comorbidities (Apert syndrome, Cerebral palsy, Chiari 2 malformation, Patau syndrome, Noonan syndrome, Congenital Rubella, Portal vein thrombosis, HIV, Scoliosis and VACTERL association) were 4.4 times more likely to die from sepsis [aOR=4.418 (95%CI: 1.617-12.072)]. Bacterial sepsis is a common problem among children with CHD. Gram positive bacteria were common causes. Down syndrome and other co morbidities predicted bacterial sepsis mortality. Blood culture and sensitivity tests are recommended to halt the high mortality seen in Down syndrome or those with co morbidities.

Sections du résumé

Background UNASSIGNED
Bacterial Sepsis is a serious medical problem affecting children with Congenital Heart Disease (CHD). The pattern and factors predicting outcome of bacterial sepsis have not been studied in Africa. The study aimed to describe the pattern and outcome of bacterial sepsis among children with CHD in Tikur Anbessa Specialized Hospital (TASH).
Methods UNASSIGNED
A cross-sectional study was carried out among children with CHD and sepsis at TASH between May 2017 and July 2020. Structured questionnaires were used for data collection. Statistical significance was set at P value < 0.05, and multivariable logistic regression was used to determine predictors.
Results UNASSIGNED
This study included 384 CHD children with sepsis. Proportion of culture proven bacterial sepsis was 17.1 % (66) (95% CI: 13.6-21.3). Coagulase negative staphylococcus aureus 7% (27), Staphylococcus aureus 4.4% (17) and Actinobacteria 1.8% (7) were the common isolated bacteriological agents. Death was documented in 25% (96) of study subjects. Down syndrome subjects were 2.4 times [aOR=2.416 (95%CI: 1.367-4.264)] more likely to die from sepsis. Those with associated comorbidities (Apert syndrome, Cerebral palsy, Chiari 2 malformation, Patau syndrome, Noonan syndrome, Congenital Rubella, Portal vein thrombosis, HIV, Scoliosis and VACTERL association) were 4.4 times more likely to die from sepsis [aOR=4.418 (95%CI: 1.617-12.072)].
Conclusion UNASSIGNED
Bacterial sepsis is a common problem among children with CHD. Gram positive bacteria were common causes. Down syndrome and other co morbidities predicted bacterial sepsis mortality. Blood culture and sensitivity tests are recommended to halt the high mortality seen in Down syndrome or those with co morbidities.

Identifiants

pubmed: 35813671
doi: 10.4314/ejhs.v32i3.7
pii: jEJHS.v32.i3.pg523
pmc: PMC9214734
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

523-532

Informations de copyright

© 2022 Edomgenet Tesfaye, et al.

Références

Afr Health Sci. 2013 Sep;13(3):607-12
pubmed: 24250297
Cardiol Res Pract. 2016;2016:7147234
pubmed: 27974990
Pediatrics. 1965 Aug;36:183-91
pubmed: 14320026
Lancet Respir Med. 2018 Mar;6(3):223-230
pubmed: 29508706
Int J Biol Med Res. 2015 Nov;6(1):4709-4717
pubmed: 26997847
J Glob Infect Dis. 2011 Jan;3(1):42-5
pubmed: 21572608
Curr Opin Clin Nutr Metab Care. 2005 May;8(3):249-54
pubmed: 15809526
Cardiovasc J Afr. 2013 May;24(4):141-5
pubmed: 24217047
Open Access Maced J Med Sci. 2018 Nov 08;6(11):2023-2029
pubmed: 30559854
Ethiop J Health Sci. 2020 Sep;30(5):707-714
pubmed: 33911831
Pediatr Crit Care Med. 2005 May;6(3 Suppl):S3-5
pubmed: 15857554
Arch Pediatr Adolesc Med. 2000 Feb;154(2):190-4
pubmed: 10665608
Paediatr Respir Rev. 2012 Mar;13(1):10-5
pubmed: 22208788
J Intellect Disabil Res. 1993 Dec;37 ( Pt 6):543-51
pubmed: 8124000
Arch Surg. 1998 Nov;133(11):1200-5
pubmed: 9820351
World J Pediatr Congenit Heart Surg. 2013 Apr;4(2):172-6
pubmed: 23799730
Circulation. 2010 Nov 2;122(18 Suppl 3):S862-75
pubmed: 20956229
Circulation. 1971 Mar;43(3):323-32
pubmed: 5102136
Ethiop J Health Sci. 2019 Jan;29(1):811-818
pubmed: 30700948
Intensive Care Med. 2013 Feb;39(2):165-228
pubmed: 23361625
J Trop Pediatr. 2000 Dec;46(6):357-62
pubmed: 11191148
Early Hum Dev. 2012 May;88 Suppl 2:S92-7
pubmed: 22633525
Pediatr Crit Care Med. 2005 Jan;6(1):2-8
pubmed: 15636651
Rev Bras Ter Intensiva. 2015 Jul-Sep;27(3):240-6
pubmed: 26465245
J Pediatr. 2005 Dec;147(6):748-52
pubmed: 16356424
World J Pediatr Congenit Heart Surg. 2016 Nov;7(6):727-731
pubmed: 27834766

Auteurs

Edomgenet Tesfaye (E)

Department of Pediatrics and Child Health, School of Medicine, College of Health Sciences, Addis Ababa University.

Henok Tadele (H)

Department of Pediatrics and Child Health, School of Medicine, College of Health Sciences, Addis Ababa University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH